Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PFIZER

Pfizer, Inc. is the world’s largest pharmaceutical company in the world, by sales. The New York-based company produces the No. 1-selling drug, along with other widely used prescription drugs as Lipitor, Lyriuca, Diflucan, Celebrex and Viagra. This topic covers the latest news on Pfizer.

Pfizer is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 1,246 news and 381 blog items. Read updated news, blogs, and resources about Pfizer. Find user-submitted articles and reactions on Pfizer from like-minded professionals.

News

Recent news on this topic.

J&J Raises Full-Year Profit Forecast After Dollar Boosts Salesmore

takeover in J&Js history. William Price, a Johnson & Johnson spokesman, declined to comment in an e-mail...

UPDATE 1-Omnicom Q1 profit beats Wall Streetmore

52 cents a share, a year ago. Revenue at Omnicom, whose clients include Anheuser-Busch InBev , McDonald's and Pfizer ,...

Novartis Still in Healthy Shapemore

will soon help the Swiss firm turn into the world���s biggest pharma company by revenue ahead of Pfizer Inc and Merck...

J&J-Synthes Takeover Obscuring Recalls in... 4:50 PMmore

would be the biggest deal in J&Js 125-year history, surpassing the $16.6 billion purchase of New York-based Pfizer...

What Drug Did Doctors Prescribe Most Last Year?more

all prescriptions dispensed. There are only three name-brand drugs on the list of the most commonly prescribed...

Management: Defending His Actelion Strategymore

soon be able to focus on growth again. He ran operations for firms such as U.S.-based Pfizer Inc. and Biogen Inc.

America?s Most Popular Drugsmore

first year ever when all of the ten most popular medicines in the U.S. were cheap generics. Pfizer���s best-seller...

Drug stocks have been sickly. Time to buy?more

marketing medical devices. The industry also faces a major unknown in health care reform. Restructuring strategies:...

J&J-Synthes Takeover Obscuring Recalls in... 9:46 AMmore

would be the biggest deal in J&Js 125-year history, surpassing the $16.6 billion purchase of New York-based Pfizer...

J&J-Synthes Takeover Obscuring Recalls in Makeover: Real M&Amore

would be the biggest deal in J&Js 125-year history, surpassing the $16.6 billion purchase of New York-based Pfizer...

The Zacks Analyst Blog Highlights: Eli Lilly, Wal-Mart, Pfizer, Americ...more

and the financial markets. Stocks recently featured in the blog include: Eli Lilly (NYSE: LLY), Wal-Mart (NYSE: WMT),...

Weaker Dollar Aiding Salesmore

Major U.S. drug makers including Pfizer Inc. and Eli Lilly & Co. are flying against some strong headwinds: patent...

Orchid Chemicals settles case with Pfizer Incmore

Orchid Chemicals has reached an out-of-court settlement with world?s largest drugmaker Pfizer Inc to sell a low-cost...

Synthes Confirms Takeover Talks With J&J as Shares... 4:28 PMmore

single-day decline in three months. A takeover would burden J&J, the worlds second-biggest maker of health-care...

Synthes Confirms Takeover Talks With J&J as Shares Risemore

single-day decline in three months. A takeover would burden J&J, the worlds second-biggest maker of health-care...

Health Care Sector Attracts Call-Buyersmore

By Pete Najarian, co-founder of More on XLV Business Highlights10 Dividend Stocks Increasing Payouts Market Activity...

J.&J. in Deal Talks With Synthesmore

more than $1 billion since 1998. Its largest takeover to date was its $16.6 billion purchase of Pfizer���s consumer...

Weaker Dollar Aids Drug-Makers' Salesmore

Major U.S. drug makers including Pfizer Inc. and Eli Lilly & Co. are flying against some strong headwinds: patent...

Synthes confirms J&J takeover talksmore

Extract not available.

Up 95%! No Anchor Holding Amarin Downmore

placebo at the higher dose, which is rather impressive considering the patients were already taking statins such as...

Synthes confirms merger talks with Jmore

Extract not available.

Synthes confirms talks with Johnson & Johnsonmore

Extract not available.

Bulls Betting on Health Care: Pete Najarianmore

highest price since early 2008. Multiple names in the sector have been targeted as well, including Merck and Pfizer, as...

Synthes Is Seen As a Fit for Jmore

t be reached for comment. A $20 billion transaction would eclipse J&J's $16.6 billion purchase of Pfizer Inc.

Synthes Chairman Holds Key to J&J Takeovermore

gets its way with a billion-dollar play for Synthes ���the U.S. health-care giant���s largest since buying Pfizer���s...

Top Sources: Pfizer

  • blogs.barrons.com
  • BusinessWeek
  • knowledge.wharton.upenn.edu
  • online.wsj.com
  • MarketWatch
  • Motley Fool
  • SeekingAlpha.com
  • New York Times
  • TheStreet.com
  • Forbes.com

Most Active Users in this Topic

see all contributors in Pfizer

Featured White Papers

Post a Job

Jobs in this Topic

Mobile Technical Engineering Pfizer | Collegeville, PA
Posted: Jun 11
Regulatory Submission Expert Pfizer | Groton, CT
Posted: Jun 19
Manager, US Marketing Pfizer | New York, NY
Posted: May 14
Director, HR Integration Management and Operations Pfizer | New York, NY
Posted: Jun 3
Senior Engineer, IP Telephony and Collaboration Pfizer | Groton, CT
Posted: Jun 15

Report comment contains invalid characters. ()
cancel
Search Cancel